News

@neurology_live
neurologylive.com > view > comparative-study-reveals-psychiatric-comorbidities-common-mogad-ms-nmosd-distinct-timing-patterns

Comparative Study Reveals Psychiatric Comorbidities Common in MOGAD, MS, and NMOSD, With Distinct Timing Patterns | NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Comparative Study Reveals Psychiatric Comorbidities Common in MOGAD, MS, and NMOSD, With Distinct Timing Patterns | NeurologyLive - Clinical Neurology News and Neurology Expert Insights16+ hour, 29+ min ago   (443+ words) Comparative Study Reveals Psychiatric Comorbidities Common in MOGAD, MS, and NMOSD, With Distinct Timing Patterns'NeurologyLive A new cross-sectional comparison study showed that psychiatric comorbidities were frequent in patients with myelin oligodendrocyte glycoprotein antibody'associated disease (MOGAD), relapsing-remitting multiple sclerosis (RRMS), and…...

Neurology Live
neurologylive.com > view > phase-3-revitalyz-trial-once-nightly-sodium-oxybate-idiopathic-hypersomnia-finishes-enrollment

Phase 3 REVITALYZ Trial of Once-Nightly Sodium Oxybate in Idiopathic Hypersomnia Finishes Enrollment

Phase 3 REVITALYZ Trial of Once-Nightly Sodium Oxybate in Idiopathic Hypersomnia Finishes Enrollment1+ mon, 1+ week ago   (751+ words) Phase 3 REVITALYZ Trial of Once-Nightly Sodium Oxybate in Idiopathic Hypersomnia Finishes Enrollment'Neurology Live A clinical readout from the phase 3 REVITALYZ trial (NCT06525077) testing Avadel's once-nightly sodium oxybate (Lumryz) treatment in patients with idiopathic hypersomnia (IH) is expected in Q2 2026, as the company…...